Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data
Lorenzo Nesti, Andrea Natali
Nutrition Metabolism and Cardiovascular Diseases (2017) Vol. 27, Iss. 8, pp. 657-669
Closed Access | Times Cited: 194

Showing 26-50 of 194 citing articles:

Metformin and its anti-inflammatory and anti-oxidative effects; new concepts
Ali Hasanpour Dehkordi, Abolfazl Abbaszadeh, Samareh Mir, et al.
Journal of Renal Injury Prevention (2018) Vol. 8, Iss. 1, pp. 54-61
Open Access | Times Cited: 73
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
Samson Mathews Samuel, Elizabeth Varghese, Peter Kubatka, et al.
Biomolecules (2019) Vol. 9, Iss. 12, pp. 846-846
Open Access | Times Cited: 73
Metformin Enhances Autophagy and Provides Cardioprotection in δ-Sarcoglycan Deficiency-Induced Dilated Cardiomyopathy
Hiromitsu Kanamori, Genki Naruse, Akihiro Yoshida, et al.
Circulation Heart Failure (2019) Vol. 12, Iss. 4
Open Access | Times Cited: 72
Metformin for prevention of hypertensive disorders of pregnancy in women with gestational diabetes or obesity: systematic review and meta‐analysis of randomized trials
Erkan Kalafat, Yavuz Emre Şükür, A. Abdi, et al.
Ultrasound in Obstetrics and Gynecology (2018) Vol. 52, Iss. 6, pp. 706-714
Open Access | Times Cited: 70
Heart failure in the patient with diabetes: Epidemiology, aetiology, prognosis, therapy and the effect of glucose‐lowering medications
David S.H. Bell, Edison Gonçalves
Diabetes Obesity and Metabolism (2019) Vol. 21, Iss. 6, pp. 1277-1290
Closed Access | Times Cited: 66
Metformin: A Candidate Drug for Renal Diseases
Raphaëlle Corremans, Benjamin A. Vervaet, Patrick C. D’Haese, et al.
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 42-42
Open Access | Times Cited: 64
Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy
Naranjan S. Dhalla, Anureet K. Shah, Paramjit S. Tappia
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2413-2413
Open Access | Times Cited: 63
The Use of Metformin to Increase the Human Healthspan
Veronika Piskovatska, Kenneth B. Storey, Alexander Vaiserman, et al.
Advances in experimental medicine and biology (2020), pp. 319-332
Closed Access | Times Cited: 52
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
Andrea Natali, Lorenzo Nesti, Domenico Tricò, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 44
Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis
Eugenio Hardy, Carlos Fernández-Patrón
Biomolecules (2021) Vol. 11, Iss. 3, pp. 390-390
Open Access | Times Cited: 41
A randomised, double‐blind, placebo‐controlled trial of metformin on myocardial efficiency in insulin‐resistant chronic heart failure patients without diabetes
Anders Hostrup Larsen, Niels Jessen, Helene Nørrelund, et al.
European Journal of Heart Failure (2019) Vol. 22, Iss. 9, pp. 1628-1637
Open Access | Times Cited: 52
Physical Exercise and Its Protective Effects on Diabetic Cardiomyopathy: What Is the Evidence?
Jia Zheng, Jing Cheng, Sheng Zheng, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 51
Effect of Metformin on Microvascular Endothelial Function in Polycystic Ovary Syndrome
Behnam Heidari, Amir Lerman, Antigoni Z. Lalia, et al.
Mayo Clinic Proceedings (2019) Vol. 94, Iss. 12, pp. 2455-2466
Open Access | Times Cited: 49
Metformin Use Is Associated With a Lower Risk of Hospitalization for Heart Failure in Patients With Type 2 Diabetes Mellitus: a Retrospective Cohort Analysis
Chin‐Hsiao Tseng
Journal of the American Heart Association (2019) Vol. 8, Iss. 21
Open Access | Times Cited: 47
Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin
Chenxu Ge, Minxuan Xu, Yuting Qin, et al.
Free Radical Biology and Medicine (2019) Vol. 141, pp. 67-83
Closed Access | Times Cited: 45
Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumors
Jiafeng Wan, Shiqing Xu, Jing Li, et al.
Nanoscale (2022) Vol. 14, Iss. 31, pp. 11359-11368
Closed Access | Times Cited: 24
Metformin enhances neural precursor cells migration and functional recovery after ischemic stroke in mice
Liang Zhang, Jing Zhang, Xiaoming Zhu, et al.
Experimental Brain Research (2023) Vol. 241, Iss. 2, pp. 505-515
Closed Access | Times Cited: 13
Research progress on the effects of novel hypoglycemic drugs in diabetes combined with myocardial ischemia/reperfusion injury
Tiangui Yang, Daqing Zhang
Ageing Research Reviews (2023) Vol. 86, pp. 101884-101884
Closed Access | Times Cited: 13
Metformin induction of heat shock factor 1 activation and the mitochondrial unfolded protein response alleviate cardiac remodeling in spontaneously hypertensive rats
Man Xu, Lipeng Li, Xi He, et al.
The FASEB Journal (2024) Vol. 38, Iss. 9
Closed Access | Times Cited: 5
Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in Romania
Teodor Salmen, Valeria-Anca Pietroșel, Delia Reurean‐Pintilei, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 9, pp. 1249-1249
Open Access | Times Cited: 5
Effect of a long-term treatment with metformin in dystrophic mdx mice: A reconsideration of its potential clinical interest in Duchenne muscular dystrophy
Paola Mantuano, Francesca Sanarica, Elena Conte, et al.
Biochemical Pharmacology (2018) Vol. 154, pp. 89-103
Open Access | Times Cited: 41
Heterogeneity of Metabolic Defects in Type 2 Diabetes and Its Relation to Reactive Oxygen Species and Alterations in Beta-Cell Mass
Andris Elksnis, Mats Martinell, Olof Eriksson, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 40
Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study
Andrea Natali, Lorenzo Nesti, Elena Venturi, et al.
Diabetes Obesity and Metabolism (2018) Vol. 21, Iss. 2, pp. 412-416
Open Access | Times Cited: 39
Metformin and heart failure–related outcomes in patients with or without diabetes: a systematic review of randomized controlled trials
Phiwayinkosi V. Dludla, Tawanda M. Nyambuya, Rabia Johnson, et al.
Heart Failure Reviews (2020) Vol. 26, Iss. 6, pp. 1437-1445
Closed Access | Times Cited: 34
The Function of Metformin in Aging-Related Musculoskeletal Disorders
Yanhong Song, Ziyi Wu, Ping Zhao
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22

Scroll to top